Jingmei Pan
Impact in
- Biotechnology top 2%
- Cancer Research and Treatments
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Nanoplatforms for cancer theranostics 7
-
- Extracellular vesicles in disease 2
- Co-authors
- Shaobing Zhou (14 shared papers)Xing Guo (7 shared papers)Funeng Xu (5 shared papers)Xuehui Huang (4 shared papers)Ruiting Yuan (3 shared papers)Yi Wang (2 shared papers)Yi Wang (1 shared paper)Xilin Li (2 shared papers)
- Journals
- Nano Letters (4 papers)Journal of Controlled Release (2 papers)Advanced Materials (2 papers)Biomaterials (2 papers)Chemosphere (1 paper)
- Partner nations
- China
In The Last Decade
Jingmei Pan
19 papers receiving 1.1k citations
Jingmei Pan's Hit Papers
Peers
Comparison fields: 5 of 93
- Biotechnology 299
- Immunology 297
- Biomedical Engineering 611
- Biomaterials 146
- Neurology 66
Countries citing papers authored by Jingmei Pan
This map shows the geographic impact of Jingmei Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingmei Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingmei Pan more than expected).
Fields of papers citing papers by Jingmei Pan
This network shows the impact of papers produced by Jingmei Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingmei Pan. The network helps show where Jingmei Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Jingmei Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy Hit paper breakdown → | 2021 | 240 |
| 2 | Bacteria‐Based Cancer Immunotherapy Hit paper breakdown → | 2021 | 239 |
| 3 | 2021 | 113 | |
| 4 | 2023 | 112 | |
| 5 | 2021 | 96 | |
| 6 | 2020 | 85 | |
| 7 | 2023 | 66 | |
| 8 | 2017 | 45 | |
| 9 | 2022 | 31 | |
| 10 | 2020 | 26 | |
| 11 | 2025 | 17 | |
| 12 | 2016 | 12 | |
| 13 | 2016 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2025 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2025 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2026 | 0 |
About Jingmei Pan
Jingmei Pan is a scholar working on Biomedical Engineering, Molecular Biology, Immunology, Neurology and Oncology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Immune cells in cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Heavy metals in environment (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Biotechnology (299 citations), Immunology (297 citations), Biomedical Engineering (611 citations), Biomaterials (146 citations) and Neurology (66 citations). Jingmei Pan has collaborated with scholars based in China. Frequent co-authors include Shaobing Zhou, Xing Guo, Funeng Xu, Xuehui Huang, Ruiting Yuan, Yi Wang, Yi Wang, Xilin Li, Xing Guo and Xuehui Huang. Their work appears in journals such as Nano Letters, Journal of Controlled Release, Advanced Materials, Biomaterials and Chemosphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.